| Name | Section 182: Microbiome Metabolomics and SCFA Therapy in CBS/PSP |
| Summary | Therapeutic interventions targeting short-chain fatty acid replacement, microbiome-derived metabolite restoration, and personalized probiotics for corticobasal syndrome and progressive supranuclear palsy |